Skip to main content

Phytochemical constituents and biological activities of Salvia macrosiphon Boiss.


Salvia macrosiphon Boiss. is an aromatic perennial herb belonging to the family Lamiaceae. Phytochemical studies and biological activities of this plant have been rarely documented in the literature. The current study aimed to investigate antibacterial and cytotoxic activity of different fractions of aerial parts of S. macrosiphon. Also, we tried to isolate and identify cytotoxic compounds from the plant. In this respect, the hydroalcoholic extract of the corresponding parts of the plant was fractionated into four fractions. Then, antibacterial and cytotoxic activity of each fraction were examined. It was found that the chloroform fraction had a good antibacterial activity against gram-positive and gram-negative bacteria. The most potent cytotoxicity was also obtained by the n-hexane fraction comparing with etoposide as the reference drug which was selected for the study and characterization of secondary metabolites. Accordingly, 13-epi manoyl oxide (1), 6α-hydroxy-13-epimanoyl oxide (2), 5-hydroxy-7,4'-dimethoxyflavone (3), and β-sitosterol (4) were isolated and evaluated for their cytotoxic activity. Among them, compound 1 revealed significant cytotoxicity against A549, MCF-7, and MDA-MB-231. It merits mentioning that it showed high selectivity index ratio regarding the low cytotoxic effects on Human Dermal Fibroblast which can be considered as a promising anticancer candidate.


Salvia is the largest genus among the Lamiaceae family members and possesses more than 1000 species which are widely distributed around the world. The Iranian flora comprises 61 Salvia species, 17 of which are endemic [1]. A number of Salvia genus with valuable biological activities are commercially important and used as a flavoring agent in foods, cosmetics, perfumery, and pharmaceutical industries [2, 3]. The name of Salvia comes from the Latin word “salvare” meaning “to heal”, endorsing its medical applications for thousands of years [4]. Salvia species have been widely used since ancient times for the treatment of different diseases such as colds, bronchitis, tuberculosis, menstrual disorders, and haemorrhage [5]. In this respect, antiproliferative effects of Salvia species on human tumor cell lines [6], the efficacy of S. miltiorrhiza for the treatment of cardiovascular and cerebrovascular diseases [7], antimicrobial and insecticidal activities of essential oil of Turkish S. hydrangea [8], antioxidant, immunomodulatory, antiinflammatory, antimicrobial, and insecticidal activities of S. mirzayanii [9], acetylcholine esterase and melanin synthesis inhibitory activities of S. officinalis [10], potent cytotoxicity, antioxidant, α-amylase, and α-glucosidase inhibitory activities of essential oil of S. syriaca [11], antibacterial activity of salvia officinalis against periodontopathogens [12], and antifungal activity of Salvia desoleana Atzei & Picci essential oil [13] have absorbed lots of attention. Furthermore, different components isolated from Salvia species have shown desired biological activity, e.g. antioxidant activity of abietane diterpenoids from Salvia barrelieri [14], antiprotozoal activity of triterpenoids from Salvia hydrangea [15], and cytotoxic activity of diterpenoids isolated from Salvia hypargeia [16].

Herein, focusing on discovering bioactive secondary metabolites from Iranian Salvia species [17], we studied the aerial parts of Salvia macrosiphon Boiss., Wild sage known as “Marvak” in Persian [18]. The plant is an endemic species growing in the west and center of Iran, and has been used in Iranian traditional medicine as diuretic, carminative and anti-flatulent [19]. Although, S. macrosiphon has been commonly used in traditional medicine, a few phytochemical studies have been developed. In this respect, flavonoids and phenolic compounds (e.g. apigenin and luteolin derivatives, and rosmarinic acid), β-sitosterol, and diterpenes (e.g. 13-epi-manoyl oxide) have been isolated and reported [20, 21]. In this work, we evaluated antibacterial and cytotoxic activities of different fractions of the aerial parts of S. macrosiphon and focusing on the efficacy of the n-hexane fraction, four compounds including diterpenes (1, 2), flavonoid (3), and steroid (4) were isolated and identified which one of them, compound 2 was reported for the first time for this plant (Fig. 1).

Fig. 1

Structure of isolated compounds from S. macrosiphon

Materials and methods

General experimental procedures

NMR (nuclear magnetic resonance, as 13C-NMR, 1H-NMR) spectra were recorded on an Avance III spectrometer (Bruker) operating at 400.20 MHz for 1H and 100.63 MHz for 13C. Solvents for the extraction and column chromatography (CC) were of technical grade and redistilled before use. Silica gel for CC (70–230 mesh) and precoated silica gel F254 (20 × 20 cm) plates for TLC, both supplied by the Merck were used. Deuterated solvents (100 atom %D) were from Armar Chemicals. TLC plates were visualized under UV light (254 and 366 nm) and by spraying with 0.5% anisaldehyde in MeOH, followed by heating at 150 °C.

Chemical and reagents

3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Dulbecco’s Modified Eagle’s Medium (DMEM), penicillin–streptomycin, trypsin–EDTA and fetal bovine serum (FBS) were purchased from Gibco BRL (Life Technologies, Paisley, Scotland). Propidium iodide (PI), 4-6-diamidino-2-phenylindole (DAPI), dimethyl sulfoxide (DMSO), acridine orange and ethidium bromide were purchased from Sigma-Aldrich chemical Co. (St. Louis, MO, USA).

Plant material

The flowering aerial parts of Salvia macrosiphon Boiss. were collected at full flowering stage from Nurabad Mamassani, located in Fars province, Iran, in May 2014. The specimen of the plant was identified and authenticated by Professor G. Amin and deposited at the Herbarium of Faculty of Pharmacy, Tehran University of Medical Sciences (voucher specimen No.6762-TEH).

Cytotoxic activity by MTT assay

Two different human breast cancer cell lines (MCF-7 and MDA-MB-231), lung cancer cell line (A-549) and normal cell (Human Dermal Fibroblast) were purchased from Pasture Institute of Iran, Tehran, Iran. The medium of RPMI 1640 (PAA, Germany) including sodium bicarbonate and N-hydroxyethylpiperazone-n-2-ethanesulfonic Acid (HEPES, Biosera, England) was used to maintain the cell lines. The medium was enriched with fetal bovine serum (FBS; Gibco, USA) and antibiotics. Then, incubated in air atmosphere enriched 5% CO2 at 37 °C. The cytotoxic activity of all fractions and compounds were examined by the MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) (Sigma-Aldrich, USA) assay.

Antibacterial activity

In vitro antibacterial activity of all fractions was assessed against gram-positive and negative bacteria (Staphylococcus aureus ATCC 6538P and Escherichia coli ATCC 8739). Minimum inhibitory concentration (MIC) was determined by broth micro-dilution method [22]. Serial dilutions of fractions and antimicrobial agents were prepared in 96-well plates by using (Mueller-Hinton Broth) MHB, and was made in a concentration ranging from 0.125 to 64 mg/mL Mueller-Hinton Broth (MHB) medium. The standard saline solution was prepared to get inoculants turbidity solution equal to 0.5 McFarland standards. The inoculants of the microbial strains were prepared from 20 h bacterial culture that were adjusted to 0.5 McFarland standard turbidity and were further diluted (1:100) using MHB medium just before adding to the serially diluted samples. The plates were incubated for 24 h at 37 °C and MIC values were recorded as the lowest concentrations which could inhibit visible growth of microorganisms. Each experiment was done in triplicate. The ampicillin was used as the standard antibacterial agent.

Extraction and isolation

The air-dried powdered aerial parts of S. macrosiphon (1.8 kg) were crushed and extracted with methanol (8 × 8 L) at room temperature for 7 days. The extract was concentrated under vacuum to afford dark green gummy residue (90.0 g). The crude methanol extract was mixed with water (700 mL) to form a suspension and partitioned successively with n-hexane, chloroform and ethyl acetate to yield n-hexane (40.0 g), chloroform (20.0 g), ethyl acetate (4.0 g) and water soluble (26.0 g) fractions.

The n-hexane fraction (20.0 g) was then loaded on a silica gel column (700 g, 70–230 mesh, 10 × 30 cm) and it components were separated with a gradient mixture of n-hexane and dichloromethane (100:0 to 0:100) as eluent, followed by increasing concentration of acetone (up to 100%) in dichloromethane. The effluents were combined to 25 fractions (F1–F25) based on TLC patterns (bands were detected on TLC under UV or by heating after spraying with 0.5% anisaldehyde in methanol).

Fraction F6 [30 mg, eluted with dichloromethane-petroleum ether (50:50)] was separated over a silica gel CC (50 g, 70–230 mesh, 1.5 × 60 cm) with a gradient mixture of chloroform/acetone (100/0 to 80/20) as eluent, to afford seven subfractions (6a-6 g). Subfraction 6f was further purified by prep. TLC [chloroform-acetone (95:5)] to afford β-sitosterol (4). Fraction F7 [100 mg, eluted with dichloromethane-petroleum ether (60:40)] was subjected to silica gel CC (70 g, 70–230 mesh, 2 × 80 cm) and eluted with chloroform-petroleum ether (70:30) to give apigenin-4’,7-dimethylether (3). From fraction F15 [3 g, eluted with dichloromethane-acetone (80:20)], crude crystals were obtained which were recrystallized from chloroform to afford 13-epi manoyl oxide (1). Fraction F17 [200 mg, eluted with dichloromethane-acetone (80:20)] was subjected to silica gel CC (65 g, 70–230 mesh, 2 × 75 cm) with chloroform-acetone (70:30) as eluent and subfractions (17a-17d) were obtained. Subfraction 17b was further purified by prep. TLC [chloroform-acetone (80:20)] to afford 6α-hydroxy-13-epimanoyl oxide (2). Their structure was elucidated by NMR spectroscopy and electrospray ionization mass spectrometry in comparison to the literature for 13-epi manoyl oxide 1 [21], 6α-hydroxy-13-epimanoyl oxide 2 [23], 5-hydroxy-7,4'-dimethoxyflavone 3 [20], and β-Sitosterol 4 [21].

13-Epi manoyl oxide (1)

White amorphous powder (100 mg). mp: 96–98 °C. 1H NMR (CDCl3, 400 MHz): δ = 5.92 (1H, dd, J = 17.3, 10.7 Hz, H-14), 5.20 (1H, dd, J = 17.3, 1.1 Hz, H-15), 4.98 (1H, dd, J = 10.7, 1.1 Hz, H-15), 1.24 (3H, s, Me-16), 1.15 (3H, s, Me-17), 0.86 (3H, s, Me-18), 0.78 (6H, s, Me-19, Me-20). 13C NMR [100 MHz, CDCl3, based on DEPT, HMQC and HMBC experiments]: Table 1. Electron ionization mass spectrometry (EI-MS) 70 eV, m/z: 290 [M]+, 275, 257, 272, 257, 191, 177, 149, 137, 121, 109, 107, 95, 81, 69, 67, 57, 55, 43.

6α-Hydroxy-13-epimanoyl oxide (2)

White amorphous powder (5 mg). mp: 95–98 °C. 1H NMR (CDCl3, 400 MHz) δ = 5.92 (1H, dd, J = 7.4, 10.8 Hz, H-14), 5.19 (1H, dd, J = 17.4, 1.4 Hz, H-15), 5.00 (1H, dd, J = 10.8, 1.4 Hz, H-15), 4.41 (1H, q, J = 3.1 Hz, H-6), 1.34 (3H, s, Me-17), 1.24 (3H, s, Me-16), 1.18 (3H, s, Me-18), 1.17 (3H, s, Me-19), 0.96 (3H, s, Me-20). 13C NMR (100 MHz, CDCl3, based on DEPT, HMQC and HMBC experiments): Table 1. EI-MS 70 eV, m/z: 306 [M]+, 291, 288, 273, 150, 135, 107, 123.

5-Hydroxy-7,4’-dimethoxyflavone (3)

Yellow needles (5 mg). mp: 171–174 °C. 1H NMR (CDCl3, 400 MHz) δ = 12.82 (1H, s, OH-5), 7.84 (2H, d, J = 8.9 Hz, H-2',H-6'), 7.02 (2H, d, J = 8.9 Hz, H-3', H-5'), 6.58 (1H, s, H-3), 6.48 (1H, d, J = 2.3 Hz, H-8), 6.37 (1H, d, J = 2.3 Hz, H-6), 3.90 (3H, s, OMe-7), 3.88 (3H, s, OMe-4'). EI-MS m/z :298 [M]+, 297, 270, 269, 255, 166, 138, 132.

β-Sitosterol (4)

Colorless needles (7 mg). mp: 132–136 °C. 1H NMR (CDCl3, 400 MHz) δ = 5.35 (1H, d, J = 5.1 Hz, H-6), 3.57–3.47 (1H, m, H-3), 1.00 (3H, s, Me-19), 0.92 (3H, d, J = 6.4 Hz, Me-21), 0.79–0.87 (9H, m, Me-26, Me-27, Me-29 ), 0.68 (3H, s, Me-18). 13C NMR (100 MHz, CDCl3, based on DEPT, HMQC and HMBC experiments): Table 1. EI-MS m/z :414 [M]+, 396, 381, 329, 303, 273, 255, 231, 213.

Table 1 13C NMR of compound 1, 2 and 4, based on DEPT, HMQC, HMBC experiments

Results and discussion

Cytotoxic activity

Cancer is the second leading cause of death and responsible for approximately 13% of mortality in the world. The current anti-cancer drugs have shown undesirable side effects, hence, developing novel, efficient, and safe dugs is definitely in high demand [24, 25]. One of the efficient approaches to new drugs is screening herbal extracts [26]. In the present study, S. macrosiphon was selected for the possible cytotoxic activity. For this purpose, different fractions of aerial parts of the plants including n-hexane, chloroform, ethyl acetate, and water-soluble fractions were screened towards lung cancer cell line (A549) and breast cancer cell lines (MCF-7 and MDA-MB-231) as well as normal cell, human dermal fibroblasts (HDF), using MTT assay comparing with etoposide as a standard drug (Table 2). The inhibitory concentration, 50% (IC50) values (µg /mL) were calculated by linear regression analysis, expressed in mean ± SD.

Table 2 In vitro cytotoxic activity of extracts of S. macrosiphon on cancerous cell lines (A549, MCF-7, MDA-MB-231)

According to calculated IC50 values reported in Table 2, n-hexane and chloroform fractions depicted much higher cytotoxicity than ethyl acetate and water-soluble fractions. However, n-hexane fraction was found to be more potent than chloroform fraction in such a manner that it showed IC50s = 20.89, 10.24, 20.98, and 26.90 µg/mL against A549, MCF-7, MDA-MB-231, and HDF, respectively. Although the cytotoxic activity of n-hexane fraction towards A549 was a little lower than etoposide on the same cell line (IC50 = 16.58 µg/mL), its activity towards MDA-MB-231 (IC50 = 20.30 µg/mL) was as the same as etoposide (IC50 = 20.98 µg/mL). It merits mentioning that cytotoxicity of n-hexane fraction against MCF-7 (IC50 = 10.24 µg/mL) was significantly higher than etoposide (IC50 = 22.08 µg/mL). Apart from high cytotoxicity against MCF-7, the higher the selectivity index (SI) ratio (2.6) was calculated comparing with those obtained for A549 and MDA-MB-231. SI indicates the cytotoxic selectivity for an agent against cancer cells versus normal cell. The greater the SI value is, the more toxic the agent is against cancerous cells but safe against HF [27].

Table 3 Cytotoxicity of isolated compounds on cancerous (A549, MCF-7, MDA-MB-231) and normal (HDF) cell lines

With these results in hand, the n-hexane fraction was candidate for further phytochemical analysis leading to isolation and identification of compounds 14. It worth mentioning that there is no report for the cytotoxicity of those compounds except β-Sitosterol which depicted no activity [28]. Cytotoxic evaluation of isolated compounds (Table 3) demonstrated much higher cytotoxicity of 13-epi manoyl oxide (1) against all cancerous cell lines. Compound 1 showed activity against A549, MCF-7, and MDA-MB-231 with IC50s = 19.37, 15.79, 22.24 µM comparing with etoposide with IC50s = 28.17, 37.51, and 34.49 µM, respectively. It should be mention that promising safety was obtained in the case of compound 1 and SI ratio was calculated as 17.4, 21.4, and 15.2 on A549, MCF-7, and MDA-MB-231 comparing with those calculated for etoposide with SI ratio of 5.6, 4.2, and 4.6. (Table 3) indicating its high efficacy with negligible side effects on normal cells.

As can be seen in Table 3, it can be concluded that 13-epi manoyl oxide 1 not only showed less toxicity towards HDF than MCF-7, but also showed more selectivity than etoposide confirming that it could be considered as a potent  candidate in anticancer drugs research and development.

Antibacterial activity

The antibacterial activity of n-hexane, chloroform, and ethyl acetate fractions of aerial parts of S. macrosiphon was evaluated against gram-positive bacterium (S. aureus) and gram-negative bacterium (E. coli) based on the agar microdilution method (Table 4). It was found that all fractions depicted moderate to good antibacterial activity with minimum inhibitory concentration (MIC) values ranged from 0.61 to 2.5 mg/mL comparing with ampicillin with MIC values of 0.5 and 0.12 µg/mL against S. aureus and E. coli, respectively. Among fractions, the chloroform fraction exhibited more potent activity against both strains (MIC = 0.61 mg/mL) and ethyl acetate fraction showed lower activity than chloroform fraction against both strains (MIC = 0.80 mg/mL). However, the n-hexane fraction with MIC values of 1.25 and 2.50 mg/mL against S. aureus and E. coli, respectively was the weakest antibacterial fraction.

Antibacterial activity of S. macrosiphon has not been fully investigated, however, Javidnia et al. reported the activity of methanolic extract of the plant against S. aureus and E. coli [29] which showed MIC values of 1 and 0.5 mg/mL, respectively. It seemed that chloroform and ethyl acetate fractions were more potent than the methanolic extract against S. aureus. However, the methanolic extract was more potent than three fractions against E. coli.

Table 4 Minimum inhibitory concentration (MIC) of fractions of S. macrosiphon against selected bacteria


In conclusion, we investigated phytochemical analysis and biological activities of aerial parts S. macrosiphon. Antibacterial evaluation of n-hexane, chloroform, and ethyl acetate fractions of the plant against S. aureus and E. coli indicated good activity with MIC values ranging from 0.61 to 2.5 mg/mL. Further studies were devoted to the investigation of cytotoxic activity. Evaluation of all fractions against A549, MCF-7, and MDA-MB-231demonstrated very good efficacy of the n-hexane fraction leading to phytochemical analysis and cytotoxic evaluation of this fraction for the first time. Among four isolated compounds (13-epi manoyl oxide 1, 6α-hydroxy-13-epimanoyl oxide 2, 5-hydroxy-7,4'-dimethoxyflavone 3, and β-sitosterol 4); compound 1 was found as effective as etoposide against A549 and MDA-MB-231 and depicted higher activity than the reference drug, against MCF-7. Another good point comes back to the higher SI ratio of compound 1 for all cancerous cell lines and normal cell (HDF) comparing with etoposide verifying its efficacy and safety. It seems that the n-hexane fraction and also chloroform fraction of S. macrosiphon can be considered for comprehensive investigations to provide an herbal anticancer agent.

Availability of data and materials

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.


IC50 :

The half maximal inhibitory concentration


Proton nuclear magnetic resonance

13C NMR:

Carbon-13 nuclear magnetic resonance

S. macrosiphin :

Salvia macrosiphon


Column Chromatography


Thin-layer chromatography


Distortionless Enhancement by Polarization Transfer


Heteronuclear multiple quantum correla


Correlation spectroscopy


Heteronuclear multiple bond correlation


Standard deviation


Selectivity index


Ultraviolet radiation




3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide


Dulbecco’s Modified Eagle’s Medium


Fetal bovine serum


Propidium iodide




Dimethyl sulfoxide


Minimum inhibitory concentration


  1. 1.

    Yi-Bing W, Zhi-Yu N, Qing-Wen S, Mei D, Hiromasa K, Yu-Cheng G, Bin C (2012) Constituents from salvia species and their biological activities. Chem Rev 112:5967–6026

    Article  Google Scholar 

  2. 2.

    Villa C, Trucchi B, Bertoli A, Pistelli L, Parodi A, Bassi AM, Ruffoni B (2009) Salvia somalensis essential oil as a potential cosmetic ingredient: Solvent-free microwave extraction, hydrodistillation, GC-MS analysis, odour evaluation and in vitro cytotoxicity assays. Int J Cosmet Sci 31:55–61

    CAS  Article  Google Scholar 

  3. 3.

    Chalchat JC, Michet A, Pasquier B (1998) Study of clones of Salvia officinalis L. yields and chemical composition of essential oil. Flavour Fragr J 13:68–70

    CAS  Article  Google Scholar 

  4. 4.

    Minhui L, Qianquan L, Chunhong Z, Na Z, Zhanhu C, Luqi H, Peigen X (2013) An ethnopharmacological investigation of medicinal Salvia plants (Lamiaceae) in China. Acta Pharm Sin B 3:273–280

    Article  Google Scholar 

  5. 5.

    Jash SK, Gorai D, Roy R (2016) Salvia genus and triterpenoids. Int J Pharm Sci Res 7:4710

    CAS  Google Scholar 

  6. 6.

    Fiore G, Nencini C, Cavallo F, Capasso A, Bader A, Giorgi G, Micheli L (2006) In vitro antiproliferative effect of six Salvia species on human tumor cell lines. Phyther Res 20:701–703

    Article  Google Scholar 

  7. 7.

    Li ZM, Xu SW, Liu PQ (2018) Salvia miltiorrhiza Burge (Danshen): A golden herbal medicine in cardiovascular therapeutics. Acta Pharmacol Sin 39:802–824

    CAS  Article  Google Scholar 

  8. 8.

    Kotan R, Kordali S, Cakir A, Kesdek M (2008) Antimicrobial and insecticidal activities of essential oil isolated from Turkish Salvia hydrangea DC. ex Benth. Biochem Syst Ecol 36:360–368

    CAS  Article  Google Scholar 

  9. 9.

    Zarshenas MM, Krenn L (2015) Phytochemical and pharmacological aspects of Salvia mirzayanii Rech. f. & Esfand. J Evid Based Complementary Altern Med 20:65–72

    CAS  Article  Google Scholar 

  10. 10.

    Sallam A, Mira A, Ashour A, Shimizu K (2016) Acetylcholine esterase inhibitors and melanin synthesis inhibitors from Salvia officinalis. Phytomedicine 23:1005–1011

    CAS  Article  Google Scholar 

  11. 11.

    Bahadori MB, Dinparast L, Zengin G, Sarikurkcu C, Bahadori S, Asghari B, Movahhedin N (2017) Functional components, antidiabetic, anti-Alzheimer’s disease, and antioxidant activities of Salvia syriaca L. Int J Food Prop 20:1761–1772

    CAS  Article  Google Scholar 

  12. 12.

    Mendes FSF, Garcia LM, Moraes TDS, Casemiro LA, Alcantara CBD, Ambrosio SR, Veneziani RCS, Miranda MLD, Martins CHG (2020) Antibacterial activity of salvia officinalis L. against periodontopathogens: An in vitro study. Anaerobe 63:102194

    CAS  Article  Google Scholar 

  13. 13.

    Sokovic MD, Brkic DD, Dzamic AM, Ristiç MS, Marin PD (2009) Chemical composition and antifungal activity of Salvia desoleana Atzei & Picci essential oil and its major components. Flavour Fragr J 24:83–87

    CAS  Article  Google Scholar 

  14. 14.

    Kabouche A, Kabouche Z, Öztürk M, Kolak U, Topcu G (2007) Antioxidant abietane diterpenoids from Salvia barrelieri. Food Chem 102:1281–1287

    CAS  Article  Google Scholar 

  15. 15.

    Farimani MM, Bahadori MB, Taheri S, Ebrahimi SN, Zimmermann S, Brun R, Amin G, Hamburger M (2011) Triterpenoids with rare carbon skeletons from Salvia hydrangea: Antiprotozoal activity and absolute configurations. J Nat Prod 74:2200–2205

    Article  Google Scholar 

  16. 16.

    Ulubelen A, Topçu G, Chai HB, Pezzuto JM (1999) Cytotoxic activity of diterpenoids isolated from Salvia. hypargeia Pharm Biol 37:148–151

    CAS  Article  Google Scholar 

  17. 17.

    Kahnamoei MB, Tabefam M, Ebrahimi SN, Danton O, Hamburger M, Farimani MM (2019) Chemical constituents from the ethyl acetate extract of salvia hydrangea. Nat Prod Commun 14:1–4

    Google Scholar 

  18. 18.

    Eftekhari M, Shams Ardekani MR, Amini M, Akbarzadeh T, Safavi M, Karimpour Razkenari E, Khanavi M (2017) Biological activities of the essential oil and total extract of Salvia macrosiphon Boiss. J Basic Clin Pharm 8:82–86

    CAS  Google Scholar 

  19. 19.

    Hamedi A, Jamshidzadeh A, Ahmadi S, Sohrabpour M, Zarshenas MM (2016) Salvia macrosiphon seeds and seed oil: pharmacognostic, anti-inflammatory and analgesic properties. Int Res J Pharm 3:27–37

    CAS  Google Scholar 

  20. 20.

    Gohari AR, Ebrahimi H, Saeidnia S, Foruzani M, Ebrahimi P, Ajani Y (2011) Flavones and flavone glycosides from salvia macrosiphon boiss. Iran J Pharm Res 10:247–251

    CAS  PubMed  PubMed Central  Google Scholar 

  21. 21.

    Matloubi Moghddam F, Moridi Farimani M, Taheri S, Tafazoli M, Amin G (2008) Chemical constituents from Salvia macrosiphon. Chem Nat Compd 44:518–519

    CAS  Article  Google Scholar 

  22. 22.

    Kafshgari HS, Yazdanian M, Ranjbar R, Tahmasebi E, Ghazi Mirsaeed SR, Tebyanian H, Ebrahimzadeh MA, Goli HR (2019) The effect of Citrullus colocynthis extracts on Streptococcus mutans, Candida albicans, normal gingival fibroblast and breast cancer cells. J Biol Res 92:30–33

    Google Scholar 

  23. 23.

    Conner AH, Rowe JW (1977) New neutral diterpenes from southern pine tall oil. Phytochemistry 16:1777–1781

    CAS  Article  Google Scholar 

  24. 24.

    Remesh A (2012) Toxicities of anticancer drugs and its management. Int J Basic Clin Pharmacol 1:2

    Article  Google Scholar 

  25. 25.

    Kroschinsky F, Stölzel F, Bonin SV, Beutel G, Kochanek M, Kiehl M, Schellongowski P (2017) New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management. Crit Care 21:1–11

    Article  Google Scholar 

  26. 26.

    Vinayak M (2018) Molecular action of herbal antioxidants in regulation of cancer growth: scope for novel anticancer drugs. Nutr Cancer 70:1199–1209

    CAS  Article  Google Scholar 

  27. 27.

    Haji Abolhasani M, Safavi M, Goodarzi MT, Kassaee SM, Azin M (2018) Identification and anti-cancer activity in 2D and 3D cell culture evaluation of an Iranian isolated marine microalgae Picochlorum sp. RCC486. DARU. J Pharm Sci 26:105–116

    Google Scholar 

  28. 28.

    Rustaie A, Hadjiakhoondi A, Akbarzadeh T, Safavi M, Samadi N, Sabourian R, Khanavi M (2018) Phytochemical Constituents and Biological Activities of Salvia suffruticosa. Res J Phamacogn 5:25–32

    CAS  Google Scholar 

  29. 29.

    Javidnia K, Miri R, Assadollahi M, Gholami M, Ghaderi M (2009) Screening of selected plants growing in iran for antimicrobial activity. Iran J Sci Technol Trans A Sci 33:329–333

    Google Scholar 

Download references


The authors acknowledged the support from Tehran University of Medical Sciences.


This work was supported by grants from the Research Council of Tehran University of Medical Sciences with project No. 97-01-33-36289.

Author information




MBK participated in the phytochemical studies, characterization of compounds, and preparation of the manuscript. ME contributed to the selection of the plant for the present study. MRSA and MK supervised all project activities. TA supervised biological activities. MS participated in the characterization of compounds and preparation of the manuscript. HJ conducted the antibacterial assay. MS, SS and NZ participated in assessment of cytotoxic activity. All authors read and approved the final manuscript. 

Corresponding author

Correspondence to Mahnaz Khanavi.

Ethics declarations

Ethics approval and consent to participate

The manuscript does not contain studies with animal subjects.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Balaei-Kahnamoei, M., Eftekhari, M., Ardekani, M.R.S. et al. Phytochemical constituents and biological activities of Salvia macrosiphon Boiss.. BMC Chemistry 15, 4 (2021).

Download citation


  • Antibacterial
  • Cytotoxic
  • Lamiaceae
  • Salvia macrosiphon Boiss.